Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5]

被引:56
|
作者
Phelps, Charles E. [1 ]
Lakdawalla, Darius N. [2 ]
Basu, Anirban [3 ]
Drummond, Michael F. [4 ]
Towse, Adrian [5 ]
Danzon, Patricia M. [6 ]
机构
[1] Univ Rochester, Polit Sci, Econ, Publ Hlth Sci, 30250 South Highway 1, Gualala, CA 95445 USA
[2] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
[5] Off Hlth Econ, London, England
[6] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA
关键词
aggregation; cost-effectiveness; equity; multi-dimensioned benefits; COST-EFFECTIVENESS ANALYSIS;
D O I
10.1016/j.jval.2017.12.010
中图分类号
F [经济];
学科分类号
02 ;
摘要
The fifth section of our Special Task Force report identifies and discusses two aggregation issues: 1) aggregation of cost and benefit information across individuals to a population level for benefit plan decision making and 2) combining multiple elements of value into a single value metric for individuals. First, we argue that additional elements could be included in measures of value, but such elements have not generally been included in measures of quality-adjusted life years. For example, we describe a recently developed extended cost-effectiveness analysis (ECEA) that provides a good example of how to use a broader concept of utility. ECEA adds two features measures of financial risk protection and income distributional consequences. We then discuss a further option for expanding this approach augmented CEA, which can introduce many value measures. Neither of these approaches, however, provide a comprehensive measure of value. To resolve this issue, we review a technique called multicriteria decision analysis that can provide a comprehensive measure of value. We then discuss budget-setting and prioritization using multicriteria decision analysis, issues not yet fully resolved. Next, we discuss deliberative processes, which represent another important approach for population- or plan-level decisions used by many health technology assessment bodies. These use quantitative information on CEA and other elements, but the group decisions are reached by a deliberative voting process. Finally, we briefly discuss the use of stated preference methods for developing "hedonic" value frameworks, and conclude with some recommendations in this area.
引用
收藏
页码:146 / 154
页数:9
相关论文
共 50 条
  • [1] An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]
    Garrison, Louis P., Jr.
    Pauly, Mark V.
    Willke, Richard J.
    Neumann, Peter J.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 124 - 130
  • [2] Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]
    Lakdawalla, Darius N.
    Doshi, Jalpa A.
    Garrison, Louis P., Jr.
    Phelps, Charles E.
    Basu, Anirban
    Danzon, Patricia M.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 131 - 139
  • [3] Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]
    Willke, Richard J.
    Neumann, Peter J.
    Garrison, Louis P., Jr.
    Ramsey, Scott D.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 155 - 160
  • [4] A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]
    Neumann, Peter J.
    Willke, Richard J.
    Garrison, LouisP., Jr.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 119 - 123
  • [5] Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4]
    Danzon, Patricia M.
    Drummond, Michael F.
    Towse, Adrian
    Pauly, Mark V.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 140 - 145
  • [6] A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]
    Garrison, Louis P., Jr.
    Neumann, Peter J.
    Willke, Richard J.
    Basu, Anirban
    Danzon, Patricia M.
    Doshi, Jalpa A.
    Drummond, Michael F.
    Lakdawalla, Darius N.
    Pauly, Mark V.
    Phelps, Charles E.
    Ramsey, Scott D.
    Towse, Adrian
    Weinstein, Milton C.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 161 - 165
  • [7] Reflections on the ISPOR Special Task Force on US Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy
    Garrison, Louis P., Jr.
    Neumann, Peter J.
    Willke, Richard J.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1185 - +
  • [8] Use of pharmacoeconomics information - Report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making
    Drummond, M
    Brown, R
    Fendrick, AM
    Fullerton, P
    Neumann, P
    Taylor, R
    Barbieri, M
    [J]. VALUE IN HEALTH, 2003, 6 (04) : 407 - 416
  • [9] A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force
    Bridges, John F. P.
    de Bekker-Grob, Esther W.
    Hauber, Brett
    Heidenreich, Sebastian
    Janssen, Ellen
    Bast, Alice
    Hanmer, Janel
    Danyliv, Andriy
    Low, Eric
    Bouvy, Jacoline C.
    Marshall, Deborah A.
    [J]. VALUE IN HEALTH, 2023, 26 (02) : 153 - 162
  • [10] The joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making: an interview with Marc Berger
    Berger, Marc L.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (01) : 11 - 13